The research institute already has strong ties with the pharmaceutical industry. This donation is reflective of an overall increase in translational medicine - in these changing times, the biopharma industry has a growing reliance on academia
A new Battelle report examines new trends in translational science among academia-industry collaboration, and the impact it has on basic science research.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Startup Founder Testimonial: Vitruvian from LaunchPad Central on Vimeo. There have been 2 or 3 courses in my entire education that have changed the way I think. This is one of those. For the past three years the National Science Foundation Innovation Corps has been teaching our nations best scientists how to build a Lean Startup. Close […]
Two foundations are pairing up to fund work toward new treatments for a group of diseases caused by mitochondrial dysfunction. The Alzheimer’s Drug Discovery Foundation and Foundation for Mitochondrial Medicine will award up to $200,000 to non-profit academic institutions and for-profit biotech companies. Qualifying organizations and companies should be conducting translational research for therapies that […]
Having several medical schools and hospitals in one region can lead to some keen competition, particularly when it comes to retaining staff. In the latest reflection of that competition and of the growing trend of translational medicine, Temple University Hospital in Philadelphia has poached the director of the Philadelphia-based Jefferson University Hospitals’ Center for Translational […]
Dr. Harsukh Parmar has rejoined Roche from AstraZeneca (NYSE:AZN) as the head of translational and experimental medicine for its inflammation discovery and translational area at its Nutley, New Jersey campus, according to a statement from the company. Parmar will be responsible for developing compounds to the life-cycle investment point. Additionally, he’ll also collaborate with discovery […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.